News and Trends 20 Oct 2022
License from Helmholtz Munich will enable progression of brain cancer treatment
A treatment for one of the most aggressive and difficult to treat cancers is the focus of a licensing option that has been executed by Isotope Technologies Munich SE (ITM).…